When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.
Conclusion & alert: CVE-2020-16198 is rated Low Risk (23.6/100): CVSS Medium severity, with low exploitation likelihood (EPSS 0.04%). Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2025-11-21 | 0.06% | 0.04% | -0.02% |
| 2 | 2025-11-18 | 0.04% | 0.06% | +0.02% |
| 3 | 2025-10-31 | — | 0.04% | — |
Full EPSS history (9 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 5.0 | 3.1 | MEDIUM |
|
1.6 | 3.4 | [email protected] |
| 6.3 | 3.1 | MEDIUM |
|
2.8 | 3.4 | [email protected] |
| 5.8 | 2.0 | MEDIUM |
|
6.5 | 6.4 | [email protected] |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| philips | clinical_collaboration_platform | <= 12.2.1 | cpe:2.3:a:philips:clinical_collaboration_platform:*:*:*:*:*:*:*:* |
| URL | Tags |
|---|---|
| https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01 | Third Party Advisory US Government Resource |
| https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archive |